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A B S T R A C T
Childhood infection with polyomaviruses leads to a life-long latent infection of renal and urinary tract epithelia. Rep-
lication in the reno-urinary epithelium is associated with viral cytopathic changes such as nuclear inclusions and decoy
cells. During the 2005-2009 period, cytological urine analysis was performed in 154 samples (94 male and 60 female)
from patients with kidney transplantation (n=19), simultaneous pancreas-kidney transplantation (SPKT) (n=9) and si-
multaneous kidney and liver transplantation (n=2). Urine samples were analyzed monthly following transplantation
according to the protocol. The period from transplantation to the first occurrence of decoy cells in the urine and the pe-
riod of decoy cell persistence in the urine were assessed. The presence of decoy cells (<10 and >10 decoy cells) and red
blood cells (<20 E, 20-100 E and >100 E) per cytospin smear was semiquantitatively determined, along with analysis of
inflammatory cells (neutrophilic granulocytes) and fungi. In patients with decoy cells detected, their sensitivity, specific-
ity, and negative and positive predictive value for BK virus nephropathy were calculated. Correlation of the study param-
eters was estimated by use of Kruskal-Wallis test (Statistica 7.1, StatSoft Inc., Tulsa, USA). Decoy cells were found in 30
patients (20 male and 10 female), age median 40 (range 16-69) years, at a mean of day 115 (range day 5–747) post trans-
plantation, whereas their presence was recorded for a mean of 141 (range 77–771) days. Immunohistochemical staining
of kidney biopsy sample for polyomavirus (SV40 large T-antigen) yielded positive reaction in 2/30 (7%) patients. Ery-
throcyturia was present in 29/30 patients with decoy cells. The number of decoy cells per cytospin smear generally ranged
less than 10 in 25/30 patients, whereas more than 10 decoy cells per cytospin smear were only recorded in 5/30 patients.
Immunohistochemistry produced positive finding for BK virus in one patient with SPKT and simultaneous kidney and
liver transplantation each, which was statistically significantly more common as compared with patients with kidney
transplantation alone (p=0.0244). Immunohistochemical positivity for BK virus was more significant in cases with
more than 10 decoy cells detected in cytospin smear (p=0.013). In BK nephropathy, the finding of urinary decoy cells
showed a 100% sensitivity, 84% specificity, 100% negative predictive value and 6% positive predictive value. BK virus
nephropathy remains a significant post transplantation complication.
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Introduction
Primary polyomavirus infection occurs in early child-
hood and the virus remains latent in the urinary tract
epithelium1–3. Three polyomavirus species, BK virus
(BKV), JC virus (JCV), and simian virus (SV40), cause
disease in humans4–6. BKV nephropathy is one of the
most important complications of BKV infection7,8. Im-
munosuppression of the allograft recipient can lead to re-
activation of the infection and development of nephro-
pathy resulting in allograft failure in up to 1%–5% of kid-
ney transplant recipients9. When reactivated, the virus
proliferates within the nuclei of renal tubular and uro-
thelial cells producing viral cytopathic effect manifested
with nuclear enlargement and basophilic intranuclear
inclusions10,11. Such cells known as »decoy cells« can be
identified by urine cytology. Systematic determination of
viruria with cytologic or molecular methods has emerged
153
Received for publication September 18, 2009
as the most useful tool for screening renal transplant re-
cipients as it identifies patients with polyomavirus repli-
cation in urinary tract12–17. Tissue biopsy is considered
the gold standard for documentation of BKV nephro-
pathy12. The aim of this presentation is to report data on
the evaluation of the efficacy of urine cytology in detec-
tion of BKV in renal transplant recipients.
Materials and Methods
During the 2005–2009 period, cytologic analysis of
urine was performed in 154 samples (94 male and 60 fe-
male) of patients with transplanted solid organs. In 30
cases, decoy cells were present in voided urine. The ma-
jority of patients had undergone kidney transplantation
(n=19), then simultaneous pancreas-kidney transplanta-
tion (SPKT; n=9), and simultaneous kidney-liver trans-
plantation (n=2). Urine samples were analyzed monthly
after transplantation, according to the protocol. Early in
the morning the patient voided the urine collected in the
urinary bladder overnight; the next fresh urine sample
was referred to cytology laboratory within 15 minutes of
miction; 0.5–1 mL of urine was processed in a cytocen-
trifuge at 600 rpm for 5 minutes. Slides were air-dried for
May-Grünwald-Giemsa (MGG) staining, or immediately
fixed in 95% alcohol for Papanicolaou staining. Two
slides of each urine sample were analyzed, one stained
with MGG and Papanicolaou staining method each. Time
interval between the day of transplantation and first ap-
pearance of decoy cells in the urine and period of decoy
cell persistence in the urine were assessed. Also, the
presence of red blood cells (E) per cytospin slide (<20 E,
20–100 E, and >100 E), and the presence of inflamma-
tory cells (neutrophilic granulocytes) and fungi was se-
miquantitatively determined. Kidney biopsy was perfor-
med according to the protocol (40%) or clinical indication
(53%), or immediately after transplantation (time zero
biopsy; 7%). Acute cellular rejection (ACR), acute anti-
body mediated rejection, chronic rejection, acute tubular
injury (ATI), interstitial fibrosis and tubular atrophy (IF
and TA), blood vessel changes, and presence of polyo-
mavirus (PV) on light microscopy and on immunohisto-
chemical staining (Anti-SV40 T antigen, clone PAb416,
Calbiochem) were analyzed in biopsy specimens. The
presence of other kidney diseases such as glomerular
ones and samples with normal findings (NF) were also
noted. Analysis of decoy cell appearance after transplan-
tation in days, total duration of decoy cell presence in the
urine and semiquantitative analysis of decoy cell pres-
ence was performed (<10 DC and >10 DC per smear). In
patients with decoy cells detected in urine samples, their
sensitivity, specificity, and positive and negative predic-
tive value for BK nephropathy were calculated. Correla-
tion of the study parameters was estimated by use of
non-parametric Kruskal-Wallis test (Statistica 7.1, Stat-
Soft Inc., Tulsa, USA).
Results
Decoy cells were found in 30/154 (19.5%) patients (20
male and 10 female) (Figure 1). Median age was 40
(range 16–69) years. The mean interval between kidney
transplantation and decoy cell occurrence was 115 (range
5–747) days, and mean duration of decoy cell presence
was 141 (range 77–771) days. Immunohistochemical stai-
ning of kidney biopsy for polyoma virus was positive in
2/30 (7%) patients (Figure 2). ACR was found in 10/30
(33%) and ATI in 9/30 (30%) patients. IF and TA was
found in 5/30 (17%) patients. Kidney morphology was
normal in 3/30 (10%) patients. One patient had focal seg-
mental glomerulosclerosis (FSGS) and another one had
both FSGS and ATI. Erythrocyturia was found in 29/30
patients with decoy cells (Table 1). Less than 20 erythro-
cytes per cytospin smear were recorded in 14 patients.
More pronounced erythrocyturia (>100 E) was found in
8 cases, whereas 20–100 E per cytospin smear were re-
corded in 7 patients. The number of decoy cells per smear
was less than 10 in most patients, while more than 10 de-
coy cells were only found in 5 samples. There was no cor-
relation between the finding of neutrophilic granulocytes
and fungi, and the presence of decoy cells. Immunohisto-
chemical positivity for BKV was recorded in one patient
with SPKT and another one with simultaneous liver and
kidney transplantation, which was statistically signifi-
cant as compared with patients with kidney transplanta-
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Fig. 1. Decoy cells with large hyperchromatic homogeneous nu-
clear inclusions in urinary sediment: a) May-Grûnwald-Giemsa,
x1000, b) Papanicolaou x1000.
a
b
tion alone (p=0.0244). A more significant immunohisto-
chemical positivity was recorded in cytospin smears with
more than 10 decoy cells (p=0.013). In BKV nephropa-
thy, the finding of urinary decoy cells showed a 100% sen-
sitivity, 84% specificity, 100% negative predictive value
and 6% positive predictive value.
Discussion
Infections with human polyomaviruses types JC and
BK are widespread, but the majority of affected patients
are asymptomatic. The major clinical manifestations ap-
pear to result from reactivation disease in immunocom-
promised individuals18. Although both JCV and SV40
have been implicated in some cases of polyomavirus
nephropathy, most cases seem to be caused by BKV7. Re-
nal transplant recipients receiving immunosuppressive
therapy have a 10–60% chance of polyomavirus reactiva-
tion accompanied by shedding of urothelial cells19. In our
study, 19.5% (30/154) of patients had positive urinary de-
coy cell findings, which is comparable with literature re-
ports, e.g., Hayat et al.20 35% and Drachenberg et al.21
13.8%. Viral replication begins early after transplanta-
tion and progresses through detectable stages of viruria
followed by viremia and nephropathy6,13,22–25. Viruria can
be detected by polymerase chain reaction (PCR) for BKV
DNA, reverse transcription-PCR for BKV RNA, cytology
for BKV inclusion bearing epithelial cells termed 'decoy
cells', or electron microscopy for viral patricles6,8,13,22,26.
These tests are sensitive for detecting active BKV infec-
tions but lack specificity for nephropathy because the de-
tected virus could originate anywhere along the urinary
tract6,27. Therefore, transplant kidney biopsy remains
the gold standard for diagnosing BKV nephropathy. How-
ever, in renal biopsy specimens it is often difficult to dif-
ferentiate between the tissue effects of viral pathology
and changes caused by ACR28. The decrease in immuno-
suppression needed to treat infection is opposite to the
increases that are needed to treat rejection6. Both exfo-
liative cytology and quantitation of viruria by PCR can
be used in screening renal transplant recipients, which
can aid in the identification of patients at risk of develop-
ing polyomavirus nephropathy14,29,30. Molecular tests are
more sensitive than urine cytology demonstrating viruria
in 30% of samples from renal transplant patients versus
12–16% of cytology samples displaying decoy cells29,30.
However, the proportion of patients with viruria identi-
fied by urine cytology is closer to the number of patients
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Fig. 2. BKV nephropathy in kidney biopsy: a) Basophilic inclu-
sions with a ground-glass appearance are present in individual
tubular epithelial cells – arrows (H&E, x400) b) SV40 immuno-
stain showing strong nuclear positivity of infected tubular cells,
which have enlarged nuclei corresponding to intranuclear inclu-




that develop polyomavirus nephropathy (8–10%)13,29. Hayat
et al.20 demonstrated histologically verified BKV nephro-
pathy in 7% of transplanted patients, whereas Drachen-
berg et al.21 report on the incidence of BKV and JCV
nephropathy of 5.5% and 0.9%, respectively. These data
correspond to our result on 1.3% of transplanted patients
with polyomavirus nephropathy. Nickeleit et al.31 report
on the positive predictive value of 'positive' decoy cell
analysis to predict BKV nephropathy to be 25–30%. How-
ever, the negative predictive value was greater than 99%,
i.e. »negative« decoy cell analysis indicated absence of vi-
ral nephropathy. De Las Casas et al.32 report on the sensi-
tivity of 83% and specificity of 90%, with a positive pre-
dictive value of 63% and negative predictive value of 96%
of urine cytology in detecting human polyomavirus com-
pared with electron microscopy of urine samples. The
high sensitivity and specificity with a high negative pre-
dictive value and low positive predictive value are consis-
tent with our results.
Conclusion
Urine cytology is a safe, noninvasive and sensitive
tool for the evaluation and follow-up of renal transplant
recipients and can be used as prospective screening for
BKV allograft nephropathy.
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TABLE 1
DATA OF PATIENTS WITH DECOY CELLS IN URINE SEDIMENT
Patient Sex Age (yrs) Histopathology TB KBT TO DAT PDT NDC NE F
1 B V M 45 ACR P 195 SPKT 200 119 5 6 1
2 B A M 41 ATI 0 0 SPKT 7 1 1 5 1
3 C A M 56 NF P 120 SPKT 124 1 2 8 1
4 C M F 57 ATI, FSGS P 90 SPKT 192 49 10 27 1
5 D @ M 39 NF P 30 SPKT 375 88 1 101 1
6 G B F 39 FSGS I 15 SPKT 148 1 1 2 2
7 H @ M 57 ACR I 105 K 94 117 65 4 2
8 H @ F 57 IF, TA I 150 K 102 475 1 3 1
9 I Z M 48 ACR I 225 K 213 1 54 101 1
10 J B M 36 ATI P 90 K 178 1 22 3 1
11 K Z M 69 ATI I 18 K 394 7 1 8 1
12 K I M 19 PV I 375 K+L 346 74 16 4 1
13 L D M 57 NF P 90 K 36 61 2 9 1
14 L F M 31 PV I 105 SPKT 153 771 26 29 1
15 M B M 35 IF, TA P 365 K 747 1 1 4 1
16 M D M 42 ACR P 90 K 72 164 6 37 1
17 M L M 30 ACR I 120 K 198 1 1 101 2
18 M T F 27 ATI I 47 SPKT 150 290 3 4 2
19 N A F 48 ATI P 180 K 603 257 5 5 1
20 P D M 32 ACR I K 210 1 1 41 1
21 P Z F 51 ATI I 480 K 463 80 1 93 1
22 Q B M 38 ACR I 30 K 7 355 6 101 1
23 S S F 26 ACR P 90 SPKT 85 1 1 26 1
24 S Z F 34 ATI I 4 K 5 191 3 101 1
25 S M M 67 IF, TA P 90 K 125 1 2 101 1
26 S S F 31 IF, TA 0 0 K 364 334 3 22 2
27 [ M F 16 ACR P 365 K 367 477 2 101 1
28 [ M M 47 ATI I 21 K 20 199 2 11 1
29 [ A M 41 IF, TA I K 88 1 1 9 1
30 V L M 31 ACR I 22 K+L 7 114 4 101 1
p<0.05 p<0.05
TB – type of biopsy, P – protocol biopsy, I – indicated biopsy, 0 – time zero biopsy, DAT – decoy cell appearance after transplantation (in
days), PDT – presence of decoy cells (in days), TO – transplanted organs, SPKT – simultaneous pancreas-kidney transplantation, K –
kidney, L – liver, NDC – number of decoy cells per cytospin smear, NE – number of erythrocytes per cytospin smear, Histopathology –
histopathological diagnosis of kidney biopsy, ACR – acute cellular rejection, ATI – acute tubular injury, IF – interstitial fibrosis, TA –
tubular atrophy, FSGS – focal segmental glomerulosclerosis, KBT – kidney biopsy after transplantation (in days), PV – polyomavirus,
F – fungi (1 – not present; 2 – present)
R E F E R E N C E S
1. BROWN P, TSAI T, GAJDUSEK DC, Am J Epidemiol, 102 (1975)
331. — 2. MANNON RB, Transplantation, 77 (2004) 1313. — 3. RAND-
HAWA P, DEMETRIS A, N Engl J Med, 342 (2000) 1361. — 4. KNOWLES
WA, PIPKIN P, ANDREWS N, VYSE A, MINOR P, BROWNDW, MILLER
E, J Med Virol, 71 (2003) 115. — 5. STOLT A, SASNAUSKAS K, KO-
SKELA P, LEHTINEN M, DILLNER J, J Gen Virol, 84 (2003) 1499. — 6.
BOHL DL, BRENNAN DC, Clin J Am Soc Nephrol, 2 (2007) 36. — 7.
BANVOISIN C, WEEKERS L, XHIGNESSE P, GROSCH S, MILICEVIC
M, KRZESINSKI J, Transplantation, 85 (2008) 42. — 8. GARDNER SD,
MACKENZIE EF, SMITH C, PORTER AA, J Clin Pathol, 37 (1984) 578.
— 9. HIRSCH HH, Am J Transplant, 2 (2002) 25. — 10. TRAYSTMAN
MD, GUPTA PK, SHAH KV, REISSIG M, COWLES LT, HILLIS WD,
FROST JK, Acta Cytol, 24 (1980) 501. — 11. KAHAN AV, COLEMAN DV,
KOSS LG, Am J Clin Pathol, 74 (1980) 326. — 12. HIRSCH HH, BRE-
NNAN DC, DRACHENBERG CB, GINEVRI F, GORDON J, LIMAYE AP,
MIHATSCH MJ, NICKELEIT V, RAMOS E, RANDHAWA P, SHAPIRO
R, STEIGER J, SUTHANTHIRAN M, TROFE J, Transplantation, 79
(2005) 1277. — 13. HIRSCH HH, KNOWLES W, DICKENMANN MM,
PASSWEG J, KLIMKAIT T, MIHATSCH MJ, STEIGER J, N Engl J Med,
347 (2002) 488. — 14. DRACHENBERG RC, DRACHENBERG CB, PA-
PADIMITRIOU JC, RAMOS E, FINK JC, WALI R, WEIR MR, CANGRO
CB, KLASSEN DK, KAHKED A, CUNNINGHAM R, BARTLET ST, Am
J Transplant, 1 (2001) 373. — 15. DRACHENBERG CB, PAPADIMIT-
RIOU JC, HIRSCH HH, WALI R, CROWDER C, NOGUEIRA J, CAN-
GRO CB, MENDLEY S, MIAN A, RAMOS E, Am J Transplant, 4 (2004)
2082. — 16. DRACHENBERG CB, HIRSCH HH, RAMOS E, PAPADI-
MITRIOU JC, Hum Pathol, 36 (2005) 1245. — 17. NICKELEIT V, MIHA-
TSCHMJ, Am J Transplant, 4 (2004) 838. — 18. DEMETER LM, Clinical
manifestations and diagnosis of JC, BK and other polyomavirus infections,
UpToDate, accessed 27.8.2009. Available from: URL: http://www.uptodate.
com/patients/content/topic.do?topicKey=~2Go6D5Whe7RIhnb. —
19. RANDHAVA PS, FINKELSTEIN S, SCANTLEBURY V, SHAPIRO R,
VIVAS C, JORDAN M, PICKEN MM, DEMETRIS AJ, Transplantation,
67 (1999) 103. — 20. HAYAT A, MUKHOPADHYAY R, RADHIKA S, SA-
CHDEVA MS, NADA R, JOSHI K, SAKHUJA V, JHA V, Nephrology, 13
(2008) 157–163. — 21. DRACHENBERG CB, HIRSCH HH, PAPADIMI-
TRIOU JC, GOSERT R, WALI RK, MUNIVENKATAPPA R, NOGUEIRA
J, CANGRO CB, HARIRIAN A, MENDELY S, RAMOS E, Transplanta-
tion, 84 (2007) 323. — 22. BRENNAN DC, AGHI I, BOHL DL, SCHNIT-
ZLER MA, HARDINGER KL, LOCKWOOD M, TORRENCE S, SCHUE-
SSLER R, ROBY T, GAUDREAULT-KEENER M, STORCH GA, Am J
Transplant, 5 (2005) 582. — 23. BRESSOLLETTE-BODIN C, COSTE-BU-
REL M, HOURMANT M, SEBILLE V, ANDRE-GARNIER E, IMBERT-
-MARCILLE BM, Am J Transplant, 5 (2005) 1926. — 24. LIMAYE AP,
JEROME KR, KUHR CS, FERRENBERG J, HUANG ML, DAVIS CL,
COREY L, MARSH CL, J Infect Dis, 183 (2001) 1669. — 25. NICKELEIT
V, KLIMKAIT T, BINET IF, DALQUEN P, DEL ZENERO V, THIEL G,
MIHATSCH MJ, HIRSCH HH, N Engl J Med, 342 (2000) 1309. — 26.
DING R, MEDEIROSM, DADHANIA D, MUTHUKUMAR T, KRACKER
D, KONG JM, EPSTEIN SR, SHARMAVK, SESHAN SV, LI B, SUTHAN-
THIRANM, Transplantation, 74 (2002) 987. — 27. RANDHAVA P, HO A,
SHAPIRO R, VATS A, SWALSKY P, FINKELSTEIN S, UHRMACHER J,
WECK K, J Clin Microbiol, 42 (2004) 1176. — 28. KAPILA K, NAM-
POORY MRN, JOHNY KV, PACSA AS, AL-AYADHY B, MATHEW JR,
NAIR MP, HALIM MA, GEORGE SS, FRANCIS IM, Med Princ Pract, 16
(2007) 237. — 29. DRACHENBERG CB, PAPADIMITRIOU JC, Transpl
Infect Dis, 8 (2006) 68. — 30. RANDHAWA P, HO A, SHAPIRO R, Trans-
plantation, 79 (2005) 984. — 31. NICKELEIT V, HIRSCH HH, BINET IF,
GUDAT F, PRINCE O, DALQUEN P, THIEL G, MIHATSCH MJ, J Am
Soc Nephrol, 10 (1999) 1080. — 32. DE LAS CASAS LE, HOERL HD,
BARDALES RH, PIRSCH JD, SEMPF JM, WETZEL DJ, STEWART III
J, OBERLEY TD, KURTYCZ DFI, Diagn Cytopathol, 25 (2001) 376.
VRIJEDNOST NALAZA DECOY STANICA U MOKRA]I BOLESNIKA S TRANSPLANTIRANIM
BUBREGOM
S A @ E T A K
Infekcija poliomavirusom tijekom djetinjstva uzrokuje do`ivotnu latentnu infekciju epitela bubrega i mokra}nog
sustava. Replikacija virusa u epitelnim stanicama bubrega i mokra}nog sustava udru`ena je s virusnim citopatskim
promjenama (nuklearne inkluzije) i virurijom (decoy stanice, virioni i/ili virusni proteini u mokra}i). U razdoblju od
2005. do 2009. godine citolo{ka analiza mokra}e u~injena je kod 154 bolesnika (94 mu{karaca i 60 `ena) s transplan-
tiranim solidnim organima. U uzorcima 30 bolesnika na|ene su decoy stanice. Uglavnom se radilo o transplantiranim
bubrezima (19 bolesnika), istodobnoj transplantaciji gu{tera~e i bubrega (SPKT) kod 9 bolesnika, a u 2 slu~aja se radilo
o istodobnoj transplantaciji bubrega i jetre. Obra|ivali su se svje`i uzorci mokra}e unutar 15 min od uzimanja (ne prvi
jutarnji uzorak); 0,5 mL mokra}e je centrifugirano u citocentrifugi na 600 okretaja kroz 5 minuta, a preparati su bojani
metodom po May-Grünwald-Giemsi (MGG) i Papanicolaou. Analiziralo se razdoblje od transplantacije do prve pojave
decoy stanica u mokra}i i razdoblje prisutnosti decoy stanica u mokra}i. Semikvantitativno se procjenjivala prisutnost
decoy stanica (<10 DC i >10 DC) i prisutnost eritrocita (<20 E, 20–100 E i >100 E) po citospin razmazu, a analizirao se
i nalaz upalnih stanica (neutrofilnih granulocita) i gljiva. U bolesnika kod kojih su na|ene decoy stanice izra~unavala se
osjetljivost, specifi~nost te negativna i pozitivna prediktivna vrijednost na BKV nefropatiju. Izvr{ena je me|usobna
korelacija ispitivanih pokazatelja Kruskal-Wallis testom (Statistica 7.1, StatSoft Inc., Tulsa, SAD. Decoy stanice su
na|ene kod 30 bolesnika (20 mu{karaca i 10 `ena), s medijanom dobi od 40 (16–69) godina, prosje~no nakon 115. dana
od transplantacije (5.–747. dan), a prisutnost je zabilje`ena prosje~no tijekom 141 dana (77.–771. dan). Imunohisto-
kemijskim bojenjem biopti~kog uzorka bubrega na poliomavirus (SV40 large T-antigen) pozitivna reakcija na|ena je u
2/30 (7%) bolesnika. Eritrociturija je bila prisutna kod 29/30 bolesnika s decoy stanicama. Broj decoy stanica po razma-
zu se uglavnom kretao do 10, a u svega 5 uzoraka je broj decoy stanica prelazio 10 po citospin razmazu. Imunocitoke-
mijski pozitivan nalaz na BKV na|en je u jednog bolesnika sa SPKT te u jednog bolesnika s istodobnom transplanta-
cijom jetre i bubrega, {to je statisti~ki zna~ajno prema bolesnicima kod kojih je transplantiran samo bubreg (p=0,0244).
Imunohistokemijska pozitivnost na BKV je bila zna~ajnija ako je u citospin razmazu na|eno vi{e od 10 decoy stanica
(p=0,013). Nalaz decoy stanica u mokra}i kod BKV nefropatija ima 100%-tnu osjetljivost i 84%-tnu specifi~nost te
negativnu prediktivnu vrijednost od 100% i pozitivnu prediktivnu vrijednost od 6%. Citolo{ka analiza mokra}e je osje-
tljiva i specifi~na metoda utvr|ivanja aktivne infekcije poliomavirusom, zna~ajna u probiru bolesnika s transplanti-
ranim bubrezima i prevenciji BKV nefropatije
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